BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18787116)

  • 1. Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation.
    Grégoire D; Kmita M
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14492-6. PubMed ID: 18787116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cre-loxP-Mediated Recombination: General Principles and Experimental Considerations.
    McLellan MA; Rosenthal NA; Pinto AR
    Curr Protoc Mouse Biol; 2017 Mar; 7(1):1-12. PubMed ID: 28252198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71.
    Oberdoerffer P; Otipoby KL; Maruyama M; Rajewsky K
    Nucleic Acids Res; 2003 Nov; 31(22):e140. PubMed ID: 14602933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered directionality in the Cre-LoxP site-specific recombination pathway.
    Aranda M; Kanellopoulou C; Christ N; Peitz M; Rajewsky K; Dröge P
    J Mol Biol; 2001 Aug; 311(3):453-9. PubMed ID: 11492999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous ectopic recombination in cell-type-specific Cre mice removes loxP-flanked marker cassettes in vivo.
    Eckardt D; Theis M; Döring B; Speidel D; Willecke K; Ott T
    Genesis; 2004 Apr; 38(4):159-65. PubMed ID: 15083516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using an in vivo phagemid system to identify non-compatible loxP sequences.
    Siegel RW; Jain R; Bradbury A
    FEBS Lett; 2001 Jun; 499(1-2):147-53. PubMed ID: 11418130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cre recombinase-mediated inversion using lox66 and lox71: method to introduce conditional point mutations into the CREB-binding protein.
    Zhang Z; Lutz B
    Nucleic Acids Res; 2002 Sep; 30(17):e90. PubMed ID: 12202778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using an in vivo phagemid system to identify non-compatible loxP sequences.
    Siegel RW; Jain R; Bradbury A
    FEBS Lett; 2001 Sep; 505(3):467-73. PubMed ID: 11576551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stella-Cre mice are highly efficient Cre deleters.
    Liu H; Wang W; Chew SK; Lee SC; Li J; Vassiliou GS; Green T; Futreal PA; Bradley A; Zhang S; Liu P
    Genesis; 2011 Aug; 49(8):689-95. PubMed ID: 21786403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved transgene integration into the Chinese hamster ovary cell genome using the Cre-loxP system.
    Inao T; Kawabe Y; Yamashiro T; Kameyama Y; Wang X; Ito A; Kamihira M
    J Biosci Bioeng; 2015 Jul; 120(1):99-106. PubMed ID: 25617966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The order of strand exchanges in Cre-LoxP recombination and its basis suggested by the crystal structure of a Cre-LoxP Holliday junction complex.
    Martin SS; Pulido E; Chu VC; Lechner TS; Baldwin EP
    J Mol Biol; 2002 May; 319(1):107-27. PubMed ID: 12051940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cre/loxP-mediated chromosome engineering of the mouse genome.
    Brault V; Besson V; Magnol L; Duchon A; Hérault Y
    Handb Exp Pharmacol; 2007; (178):29-48. PubMed ID: 17203650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated Cre deletion of floxed sequences in primary mouse cells is an efficient alternative for studies of gene deletion.
    Prost S; Sheahan S; Rannie D; Harrison DJ
    Nucleic Acids Res; 2001 Aug; 29(16):E80. PubMed ID: 11504888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cre recombinase activity is inhibited in vivo but not ex vivo by a mutation in the asymmetric spacer region of the distal loxP site.
    Arguello T; Moraes CT
    Genesis; 2015 Nov; 53(11):695-700. PubMed ID: 26331883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cre-mediated chromosome loss in mice.
    Lewandoski M; Martin GR
    Nat Genet; 1997 Oct; 17(2):223-5. PubMed ID: 9326948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant loxP vectors for selectable marker recycle and conditional knock-outs.
    Arakawa H; Lodygin D; Buerstedde JM
    BMC Biotechnol; 2001; 1():7. PubMed ID: 11591226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques.
    Semprini S; Troup TJ; Kotelevtseva N; King K; Davis JR; Mullins LJ; Chapman KE; Dunbar DR; Mullins JJ
    Nucleic Acids Res; 2007; 35(5):1402-10. PubMed ID: 17284462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pronuclear injection-based targeted transgenesis in mice through Cre-loxP site-specific recombination.
    Ohtsuka M
    Methods Mol Biol; 2014; 1194():3-19. PubMed ID: 25064095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient in vitro and in vivo excision of floxed sequences with a high-capacity adenoviral vector expressing Cre recombinase.
    Badorf M; Edenhofer F; Dries V; Kochanek S; Schiedner G
    Genesis; 2002 Jul; 33(3):119-24. PubMed ID: 12124944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.